Page last updated: 2024-08-16

sibutramine and piperidines

sibutramine has been researched along with piperidines in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	45 (76.27)	29.6817
2010's	14 (23.73)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Holcomb, HH; Schweitzer, JB	1
Dourish, CT; Kennett, GA; Vickers, SP; Webster, LJ; Wyatt, A	1
Vastag, B	1
Halford, JC	1
Bérubé-Parent, S; Chaput, JP; Tremblay, A	1
Kennedy, RL; Khoo, EY	1
Yanovski, SZ	1
Astrup, AV; Breum, L; Bruun, JM; Svendsen, OL; Toubro, S	1
Cheskin, LJ; Sidhaye, A	1
Letonturier, P	1
Blackburn, GL; Waltman, BA	1
Hamann, A	2
Behn, A; Ur, E	1
Halpern, A; Mancini, MC	1
Caterson, ID; Finer, N	1
Cannon, E; Lundquist, LM; Sirimaturos, M	1
Boss, O; Hofbauer, KG; Nicholson, JR	1
Hofbauer, KG; Nicholson, JR	1
Fujioka, K	1
Majumdar, SR; Padwal, RS	1
Rotthoff, T; Scherbaum, WA	1
Formiguera, X; Sierra, A	1
Bray, GA; Ryan, DH	1
Gargallo, M; Isabel Millán, A; Moreno, B; Rubio, MA	1
Zieba, R	1
Käser, L; Kolyvanos, NU; Suter, PM; Vetter, W	1
Bodary, PF; Eitzman, DT; Iglay, HB	1
Kaila, B; Raman, M	1
Nau, JY	1
Al-Zaman, Y; Aylwin, S	1
Davis, RJ; Nomikos, GG	1
Aronne, LJ; Neff, LM	1
Barnett, A; Rahim, A; Samat, A	1
Pagotto, U; Pasquali, R; Vanuzzo, D; Vicennati, V	1
Dunbar, AR; Fiksdal, BL; Filtz, CR; Hahn, TW; Jewett, DC; Levine, AS; Novinska, NL; Smith, TR; Wiebelhaus, JM	1
Narbro, K; Neovius, M	1
Aronne, LJ; Davis, SN; Foster, GD; Pagotto, U	1
Idelevich, E; Kirch, W; Schindler, C	1
Höcht, C; Mayer, MA; Puyó, A; Taira, CA	1
Faludi, G; Halmy, L; Purebl, G; Rihmer, Z	1
Choussein, S; Daskalopoulou, SS; Frangos, CC; Makri, AA; Petridou, ET	1
Ciccocioppo, R; Cifani, C; Di Francesco, C; Massi, M; Melotto, S; Righetti, C; Tessari, M; Zanoncelli, A	1
DeSantis, SM; Johansson, K; Neovius, K; Neovius, M; Rössner, S	1
Berghold, A; Horvath, K; Jeitler, K; Matyas, E; Pignitter, N; Siebenhofer, A; Siering, U; Stich, AK	1
Amundsen, MO; Berg, C; Engdahl, B; Nordeng, H	1
Blundell, JE; Rodgers, RJ; Tallett, AJ	1
Axel, AM; Hansen, G; Hansen, HH; Larsen, PJ; Mikkelsen, JD; Raben, A; Tang-Christensen, M	1
de Kaste, D; Fijałek, Z; Kaun, N; Maurin, JK; Venhuis, BJ; Vredenbregt, MV	1
Madsbad, S	1
Bornstein, SR; Chavakis, T; Lamounier-Zepter, V; Schindler, C	1
Abrams, K; Ara, R; Cooper, N; Davies, MJ; Dunkley, A; Gray, LJ; Khunti, K; Sutton, A; Warren, FC	1
Abrams, K; Ara, R; Blake, L; Cooper, N; Crowther, M; Davies, M; Dunkley, A; Gray, L; Hernández, M; Jackson, R; Khunti, K; Rees, A; Stevenson, M; Sutton, A; Warren, F	1
Bedros, JR; Medvegy, M; Pados, G; Simonyi, G	1
Colman, E	1
Kautzky-Willer, A; Lemmens-Gruber, R	1
Berghold, A; Horvath, K; Jeitler, K; Semlitsch, T; Siebenhofer, A; Siering, U	1
Baretić, M	1
Berghold, A; Horvath, K; Jeitler, K; Meschik, J; Posch, N; Semlitsch, T; Siebenhofer, A	1

Reviews

42 review(s) available for sibutramine and piperidines

Article	Year
Drugs under investigation for attention-deficit hyperactivity disorder. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:8 Topics: Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Clinical Trials as Topic; Cyclobutanes; Donepezil; Histamine Agonists; Humans; Indans; Modafinil; Nootropic Agents; Piperidines; Propylamines	2002
Clinical pharmacotherapy for obesity: current drugs and those in advanced development. Current drug targets, 2004, Volume: 5, Issue:7 Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Energy Metabolism; Feeding Behavior; Fructose; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Topiramate	2004
Obesity and cardiovascular physiology: impact of some pharmacological agents. Current vascular pharmacology, 2005, Volume: 3, Issue:2 Topics: Animals; Anti-Obesity Agents; Appetite Depressants; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Clinical Trials as Topic; Cyclobutanes; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Risk Factors	2005
[Drug treatment of obesity]. Ugeskrift for laeger, 2006, Jan-09, Volume: 168, Issue:2 Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Diethylpropion; Enzyme Inhibitors; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Time Factors; Weight Loss	2006
Pharmacologic treatment of obesity. Advances in psychosomatic medicine, 2006, Volume: 27 Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Fructose; Humans; Isoxazoles; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Selective Serotonin Reuptake Inhibitors; Topiramate; Zonisamide	2006
Pharmacotherapy to reduce visceral fat. Clinical cornerstone, 2005, Volume: 7, Issue:2-3 Topics: Anti-Obesity Agents; Coronary Disease; Cyclobutanes; Exercise; Feeding Behavior; Humans; Intra-Abdominal Fat; Lactones; Metabolic Syndrome; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant	2005
[Pharmacotherapy in the treatment of obesity]. MMW Fortschritte der Medizin, 2006, Mar-02, Volume: 148, Issue:9 Topics: Anti-Obesity Agents; Appetite Depressants; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Cyclobutanes; Enzyme Inhibitors; Exercise; Humans; Lactones; Lipase; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Time Factors; Weight Loss	2006
The obesity epidemic and its cardiovascular consequences. Current opinion in cardiology, 2006, Volume: 21, Issue:4 Topics: Appetite Depressants; Body Fat Distribution; Body Mass Index; Cardiovascular Diseases; Cyclobutanes; Humans; Inflammation; Insulin Resistance; Intra-Abdominal Fat; Lactones; Life Style; Lipid Metabolism; Metabolic Syndrome; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Thiazolidinediones; Waist-Hip Ratio	2006
Pharmacological treatment of obesity. Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:2 Topics: Amphetamines; Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Energy Metabolism; Homeostasis; Humans; Lactones; Mazindol; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Weight Loss	2006
Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk. Asia Pacific journal of clinical nutrition, 2006, Volume: 15 Suppl Topics: Anti-Obesity Agents; Cardiovascular Diseases; Cyclobutanes; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Risk Factors; Safety; Treatment Outcome	2006
Pharmacologic treatment for obesity. Options for today...and tomorrow. Advance for nurse practitioners, 2006, Volume: 14, Issue:8 Topics: Anti-Obesity Agents; Clinical Trials as Topic; Cyclobutanes; Drug Therapy, Combination; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Weight Loss	2006
The obesity epidemic: current and future pharmacological treatments. Annual review of pharmacology and toxicology, 2007, Volume: 47 Topics: Anti-Obesity Agents; Cyclobutanes; Disease Outbreaks; Drug Design; Drugs, Investigational; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant	2007
Pharmacotherapy of obesity. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2006, Volume: 114, Issue:9 Topics: Anti-Obesity Agents; Clinical Trials as Topic; Cyclobutanes; Drug Design; Energy Metabolism; Homeostasis; Humans; Lactones; Life Style; Models, Biological; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Technology, Pharmaceutical	2006
Metabolic syndrome treatment strategies. Pharmacotherapy, 2006, Volume: 26, Issue:12 Pt 2 Topics: Appetite Depressants; Cardiovascular Diseases; Cyclobutanes; Exercise; Humans; Metabolic Syndrome; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Risk Factors; Weight Loss	2006
Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet (London, England), 2007, Jan-06, Volume: 369, Issue:9555 Topics: Anti-Obesity Agents; Blood Pressure; Cholesterol, HDL; Cyclobutanes; Half-Life; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Weight Loss	2007
[Pharmacotherapy of obesity]. Medizinische Monatsschrift fur Pharmazeuten, 2006, Volume: 29, Issue:12 Topics: Anti-Obesity Agents; Anticonvulsants; Cyclobutanes; Fructose; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Topiramate	2006
[New therapeutic aspects for the control of risk factors in obesity]. Medicina clinica, 2007, Apr-07, Volume: 128, Issue:13 Topics: Anti-Obesity Agents; Cyclobutanes; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant	2007
Drug treatment of the overweight patient. Gastroenterology, 2007, Volume: 132, Issue:6 Topics: Animals; Anti-Obesity Agents; Clinical Trials, Phase II as Topic; Cyclobutanes; Humans; Lactones; Obesity; Orlistat; Overweight; Piperidines; Pyrazoles; Rimonabant; Treatment Outcome	2007
Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Public health nutrition, 2007, Volume: 10, Issue:10A Topics: Anti-Obesity Agents; Cyclobutanes; Humans; Lactones; Life Style; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Safety; Treatment Outcome; Weight Loss	2007
[Obesity: a review of currently used antiobesity drugs and new compounds in clinical development]. Postepy higieny i medycyny doswiadczalnej (Online), 2007, Oct-19, Volume: 61 Topics: Anti-Obesity Agents; Clinical Trials as Topic; Cyclobutanes; Humans; Lactones; Neurotransmitter Agents; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Treatment Outcome	2007
[Obesity in adults]. Praxis, 2007, Oct-17, Volume: 96, Issue:42 Topics: Adult; Aged; Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Body Mass Index; Cyclobutanes; Diagnosis, Differential; Enzyme Inhibitors; Humans; Lactones; Male; Middle Aged; Obesity; Obesity, Morbid; Orlistat; Overweight; Piperidines; Prognosis; Pyrazoles; Rimonabant; Time Factors; Weight Loss	2007
Strategies to reduce vascular risk associated with obesity. Current vascular pharmacology, 2007, Volume: 5, Issue:4 Topics: Adiponectin; Anti-Obesity Agents; Cardiovascular Diseases; Cyclobutanes; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Risk Factors	2007
[Pharmacotherapy of obesity]. Der Internist, 2008, Volume: 49, Issue:1 Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Treatment Outcome	2008
Obesity: a review of pathogenesis and management strategies. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2008, Volume: 22, Issue:1 Topics: Anti-Obesity Agents; Bariatric Surgery; Behavior Therapy; Caloric Restriction; Cyclobutanes; Dietary Carbohydrates; Dietary Fats; Exercise; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Weight Loss	2008
Emerging concepts in the medical and surgical treatment of obesity. Frontiers of hormone research, 2008, Volume: 36 Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide	2008
Pharmacotherapy for obesity. Current atherosclerosis reports, 2007, Volume: 9, Issue:6 Topics: Amyloid; Anti-Obesity Agents; Appetite Depressants; Body Weight; Chronic Disease; Comorbidity; Cyclobutanes; Exenatide; Gastrointestinal Hormones; Humans; Islet Amyloid Polypeptide; Lactones; Leptin; Metformin; Obesity; Orlistat; Peptides; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Venoms	2007
Pharmacotherapy for obesity in menopausal women. Menopause international, 2008, Volume: 14, Issue:2 Topics: Anti-Obesity Agents; Bariatric Surgery; Cyclobutanes; Diabetes Mellitus, Type 2; Exenatide; Female; Humans; Hypoglycemic Agents; Lactones; Menopause; Metformin; Obesity; Orlistat; Peptides; Piperidines; Pyrazoles; Rimonabant; Risk Factors; Venoms	2008
Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review. International journal of obesity (2005), 2008, Volume: 32, Issue:12 Topics: Anti-Obesity Agents; Appetite Depressants; Body Mass Index; Cost-Benefit Analysis; Cyclobutanes; Europe; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Quality-Adjusted Life Years; Rimonabant; Treatment Outcome; United States	2008
Current pharmacotherapeutic concepts for the treatment of obesity in adults. Therapeutic advances in cardiovascular disease, 2009, Volume: 3, Issue:1 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Combined Modality Therapy; Cyclobutanes; Enzyme Inhibitors; Humans; Lactones; Lipase; Obesity; Orlistat; Piperidines; Prevalence; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Risk Reduction Behavior; Treatment Outcome; Weight Loss	2009
Recent advances in obesity pharmacotherapy. Current clinical pharmacology, 2009, Volume: 4, Issue:1 Topics: Animals; Anti-Obesity Agents; Cardiovascular Diseases; Cyclobutanes; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant	2009
[Association of obesity and depression]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2008, Volume: 10, Issue:4 Topics: Anti-Obesity Agents; Antidepressive Agents; Appetite Depressants; Appetite Regulation; Bipolar Disorder; Circadian Rhythm; Cyclobutanes; Depression; Depressive Disorder, Major; Dietary Carbohydrates; Energy Intake; Ghrelin; Humans; Hypothalamo-Hypophyseal System; Insulin Resistance; Leptin; Obesity; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rimonabant; Seasonal Affective Disorder; Sleep Wake Disorders; Surveys and Questionnaires; Weight Gain; Weight Loss	2008
Effect of antiobesity medications in patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism, 2009, Volume: 11, Issue:7 Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Appetite Depressants; Body Weight; Cyclobutanes; Diabetes Mellitus, Type 2; Female; Humans; Lactones; Male; Middle Aged; Obesity; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Receptor, Cannabinoid, CB1; Rimonabant; Treatment Outcome; Weight Loss; Young Adult	2009
Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2009, Volume: 10, Issue:5 Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Humans; Lactones; Medication Adherence; Odds Ratio; Orlistat; Overweight; Patient Dropouts; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant	2009
Long-term effects of weight-reducing drugs in hypertensive patients. The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3 Topics: Adult; Anti-Obesity Agents; Blood Pressure; Cyclobutanes; Female; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Time; Weight Loss	2009
[Pharmacological concepts for the treatment of obesity - a therapeutic meander?]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:31-32 Topics: Adverse Drug Reaction Reporting Systems; Appetite Depressants; Body Weight; Brain; Combined Modality Therapy; Cyclobutanes; Diet, Reducing; Drug Approval; Drug Combinations; Drug Recalls; Drugs, Investigational; Forecasting; Humans; Obesity; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant	2011
A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity. Obesity reviews : an official journal of the International Association for the Study of Obesity, 2012, Volume: 13, Issue:6 Topics: Anti-Obesity Agents; Body Mass Index; Cyclobutanes; Humans; Lactones; Life Style; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Treatment Outcome; Weight Loss	2012
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health technology assessment (Winchester, England), 2012, Volume: 16, Issue:5 Topics: Anti-Obesity Agents; Cost-Benefit Analysis; Cyclobutanes; Drug Costs; Exercise; Female; Humans; Lactones; Male; Middle Aged; Obesity; Orlistat; Piperidines; Primary Health Care; Pyrazoles; Rimonabant; Risk Reduction Behavior; Treatment Outcome	2012
[The pharmacological treatment of obesity: past, present and future]. Orvosi hetilap, 2012, Mar-11, Volume: 153, Issue:10 Topics: Amides; Anti-Obesity Agents; Anticonvulsants; Antidepressive Agents; Basal Metabolism; Benzazepines; Benzoxazines; Body Mass Index; Bridged Bicyclo Compounds, Heterocyclic; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Fatty Acids; Female; Fenfluramine; Glucagon-Like Peptide 1; Human Growth Hormone; Humans; Intestinal Absorption; Lactones; Leptin; Life Style; Liraglutide; Male; Norepinephrine; Obesity; Obesity, Morbid; Orlistat; Piperidines; Pyrazoles; Pyridines; Receptor, Melanocortin, Type 4; Rimonabant; Satiation; Serotonin; Sodium-Glucose Transport Proteins; Sucrose; Thyroid Hormones	2012
Obesity and diabetes. Handbook of experimental pharmacology, 2012, Issue:214 Topics: Animals; Cyclobutanes; Diabetes Mellitus; Female; Humans; Incretins; Insulin; Lactones; Male; Metformin; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Sex Characteristics; Sulfonylurea Compounds	2012
Long-term effects of weight-reducing drugs in hypertensive patients. The Cochrane database of systematic reviews, 2013, Mar-28, Issue:3 Topics: Adult; Anti-Obesity Agents; Blood Pressure; Cyclobutanes; Diet, Reducing; Female; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Safety-Based Drug Withdrawals; Time; Weight Loss	2013
Obesity drug therapy. Minerva endocrinologica, 2013, Volume: 38, Issue:3 Topics: Anti-Obesity Agents; Appetite; Combined Modality Therapy; Comorbidity; Cost-Benefit Analysis; Cyclobutanes; Diabetes Mellitus, Type 2; Diet, Diabetic; Drug Combinations; Exercise Therapy; Fructose; Gastrointestinal Hormones; Humans; Incretins; Insulin; Insulin Secretion; Intestines; Lactones; Leptin; Life Style; Models, Biological; Neuropeptides; Obesity; Orlistat; Phentermine; Phytotherapy; Piperidines; Plant Preparations; Pyrazoles; Rimonabant; Topiramate	2013
Long-term effects of weight-reducing drugs in people with hypertension. The Cochrane database of systematic reviews, 2016, Mar-02, Volume: 3 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Blood Pressure; Cyclobutanes; Diet, Reducing; Female; Fructose; Humans; Hypertension; Lactones; Male; Middle Aged; Orlistat; Phentermine; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Safety-Based Drug Withdrawals; Time; Topiramate; Weight Loss	2016

Other Studies

17 other study(ies) available for sibutramine and piperidines

Article	Year
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology, 2003, Volume: 167, Issue:1 Topics: Animals; Appetite Depressants; Cannabinoids; Cyclobutanes; Dose-Response Relationship, Drug; Eating; Energy Metabolism; Male; Motor Activity; Piperidines; Pyrazoles; Rats; Rats, Zucker; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors; Weight Gain	2003
Experimental drugs take aim at obesity. JAMA, 2003, Apr-09, Volume: 289, Issue:14 Topics: Animals; Anti-Obesity Agents; Ciliary Neurotrophic Factor; Cyclobutanes; Drug Evaluation; Drugs, Investigational; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Recombinant Proteins; Rimonabant; United States; United States Food and Drug Administration	2003
New options for drug treatment of obesity in patients with Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 2005, Volume: 22 Suppl 4 Topics: Anti-Obesity Agents; Appetite Depressants; Cannabinoids; Cyclobutanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lactones; Male; Middle Aged; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant	2005
Pharmacotherapy for obesity--promise and uncertainty. The New England journal of medicine, 2005, Nov-17, Volume: 353, Issue:20 Topics: Anti-Obesity Agents; Appetite Depressants; Cannabinoid Receptor Antagonists; Cyclobutanes; Dyslipidemias; Humans; Obesity; Piperidines; Pyrazoles; Rimonabant; Weight Loss	2005
[Reducing obesity]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:1 Pt 1 Topics: Adolescent; Adult; Appetite Depressants; Body Mass Index; Cardiovascular Diseases; Child; Cyclobutanes; Female; Humans; Life Style; Male; Middle Aged; Obesity; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Risk Factors; Surveys and Questionnaires; Weight Loss	2006
[Antiobesity drugs--new limitations]. Revue medicale suisse, 2007, Nov-28, Volume: 3, Issue:135 Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Depression; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Lactones; Obesity, Morbid; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Suicide; Weight Loss	2007
Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the rat. Molecular psychiatry, 2008, Volume: 13, Issue:3 Topics: Acetylcholine; Administration, Oral; Analysis of Variance; Animals; Appetite Depressants; Cyclobutanes; Dose-Response Relationship, Drug; Male; Microdialysis; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Rats, Wistar; Rimonabant	2008
[Pharmacological therapy of obesity]. Giornale italiano di cardiologia (2006), 2008, Volume: 9, Issue:4 Suppl 1 Topics: Anti-Obesity Agents; Appetite Depressants; Body Mass Index; Bradykinin; Cannabinoid Receptor Antagonists; Cannabinoids; Cyclobutanes; Diabetes Mellitus, Type 2; Double-Blind Method; Economics, Pharmaceutical; Humans; Lactones; Lipase; Meta-Analysis as Topic; Obesity; Orlistat; Piperidines; Practice Guidelines as Topic; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Risk Factors; Time Factors; Weight Loss	2008
Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation. Psychopharmacology, 2009, Volume: 203, Issue:2 Topics: Animals; Appetite Depressants; Cyclobutanes; Discrimination Learning; Discrimination, Psychological; Eating; Food Deprivation; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Time Factors	2009
The endocannabinoid system as a target for obesity treatment. Clinical cornerstone, 2008, Volume: 9, Issue:1 Topics: Amides; Anti-Obesity Agents; Cannabinoid Receptor Modulators; Cyclobutanes; Depression; Endocannabinoids; Humans; Lactones; Life Style; Metabolic Syndrome; Obesity; Orlistat; Piperidines; Pyrazoles; Pyridines; Rimonabant; Risk	2008
Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats. Addiction biology, 2009, Volume: 14, Issue:4 Topics: Adrenocorticotropic Hormone; Animals; Anti-Obesity Agents; Appetite Depressants; Cannabinoids; Conditioning, Operant; Corticosterone; Cues; Cyclobutanes; Environment; Feeding Behavior; Female; Fluoxetine; Fructose; Humans; Hypothalamo-Hypophyseal System; Motivation; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rats; Reproducibility of Results; Rimonabant; Selective Serotonin Reuptake Inhibitors; Topiramate	2009
Use of psychotropic drugs and analgesics among users of antiobesity drugs--a population based study. Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics; Anti-Obesity Agents; Child; Cyclobutanes; Databases, Factual; Drug Interactions; Female; Humans; Lactones; Male; Middle Aged; Norway; Orlistat; Piperidines; Practice Patterns, Physicians'; Psychotropic Drugs; Pyrazoles; Rimonabant; Sex Factors; Young Adult	2010
Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats. Pharmacology, biochemistry, and behavior, 2010, Volume: 97, Issue:1 Topics: Animals; Appetite; Cyclobutanes; Drug Administration Schedule; Drug Therapy, Combination; Male; Piperidines; Pyrazoles; Rats; Reaction Time; Rimonabant; Satiety Response; Weight Gain	2010
The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant. European journal of pharmacology, 2010, Jun-25, Volume: 636, Issue:1-3 Topics: Adipose Tissue; Animals; Appetite; Biogenic Monoamines; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Cyclobutanes; Diet; Eating; Glucose Tolerance Test; Lipids; Male; Neurotransmitter Uptake Inhibitors; Obesity; Piperidines; Pyrazoles; Rats; Rimonabant; Time Factors; Weight Loss	2010
The identification of rimonabant polymorphs, sibutramine and analogues of both in counterfeit Acomplia bought on the internet. Journal of pharmaceutical and biomedical analysis, 2011, Jan-05, Volume: 54, Issue:1 Topics: Chemistry, Pharmaceutical; Chromatography, Liquid; Cyclobutanes; Drug Contamination; Fraud; Internet; Models, Chemical; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Spectroscopy, Near-Infrared; Spectrum Analysis, Raman; X-Ray Diffraction	2011
[Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review]. Ugeskrift for laeger, 2011, Feb-21, Volume: 173, Issue:8 Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Blood Pressure; Cardiovascular Diseases; Cyclobutanes; Evidence-Based Medicine; Humans; Hypertension; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Time Factors; Treatment Outcome; Weight Loss	2011
Food and Drug Administration's Obesity Drug Guidance Document: a short history. Circulation, 2012, May-01, Volume: 125, Issue:17 Topics: Adolescent; Adult; Advisory Committees; Aged; Anti-Obesity Agents; Bariatric Medicine; Body Mass Index; Child; Congresses as Topic; Cyclobutanes; Diabetes Mellitus, Type 2; Drug Approval; Drug Discovery; Female; History, 20th Century; History, 21st Century; Humans; Male; Middle Aged; Multicenter Studies as Topic; Obesity; Outcome Assessment, Health Care; Piperidines; Practice Guidelines as Topic; Pyrazoles; Randomized Controlled Trials as Topic; Reference Standards; Rimonabant; Safety-Based Drug Withdrawals; United States; United States Food and Drug Administration	2012